Lithium-associated hypothyroidism
Lithium therapy is associated with an increased risk of hypothyroidism, including clinical hypothyroidism, during long-term treatment. [1, 2] Systematic evidence shows higher clinical hypothyroidism prevalence in lithium-treated patients versus placebo and increases in thyroid-stimulating hormone (TSH). [2]
Mechanism of thyroid dysfunction with lithium
Lithium can impair thyroid hormone production and release, leading to elevated TSH and hypothyroidism. [2] This effect is reflected in increased TSH during lithium treatment. [2]
Risk magnitude for clinical hypothyroidism
Clinical hypothyroidism prevalence is increased with lithium compared with placebo (odds ratio [OR] 5.78, 95% CI 2.00 to 16.67). [2] Average TSH is increased with lithium by about 4.00 iU/mL versus placebo. [2]
Monitoring of thyroid function during long-term lithium
Long-term lithium treatment requires ongoing thyroid function monitoring as part of physical health checks. [1] A specific monitoring framework recommends thyroid function testing at baseline and then periodically during maintenance therapy. [2]
Initiation thresholds for monitoring and follow-up
Thyroid function tests should be obtained before starting lithium to document euthyroid status. [2] Further thyroid evaluation should be arranged when thyroid function test results are abnormal during monitoring. [1, 2]
Management implications when hypothyroidism develops
Identification of thyroid dysfunction during lithium therapy requires biochemical assessment of thyroid function and clinical management consistent with primary hypothyroidism care. [1] Lithium therapy can continue in many cases with appropriate thyroid hormone replacement and monitoring, since hypothyroidism is an expected complication of treatment. [1, 2]
Common pitfalls to avoid
Thyroid function monitoring omissions are a risk because lithium is associated with thyroid abnormalities that can emerge during maintenance therapy. [1, 2] Attributing symptoms solely to psychiatric disease or nonthyroid causes without thyroid function testing increases the risk of missed or delayed diagnosis. [1]
Treatment goals for thyroid replacement during lithium therapy
Biochemical euthyroidism is the monitoring goal after diagnosis of hypothyroidism during lithium therapy. [1] TSH is the key biochemical marker used to track response because lithium is associated with TSH elevation. [2]